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ABSTRACT 
Synthesis of Ester Derivatives of Resveratrol as Potential Anti-Cancer Drugs 
by 
Parasmani Pageni 
 
Resveratrol is a naturally occurring phytoalexin of the stilbene family produced by various plants 
in response to stress, UV radiation, and fungal attack. It is primarily found in peanuts, berries, 
grape skin, and red wine. Resveratrol has been found to exhibit anti-cancer, anti-inflammatory, 
anti-aging, and anti-oxidant properties. Research indicates that diets enriched with resveratrol 
containing substances result in less incidence of cancer. Unfortunately, the low bioavailability 
and solubility has been a huge setback for its potential prospects. As a result, efforts have been 
made to synthesize derivatives of resveratrol with increased solubility and bioavailability. Three 
triester novel resveratrol derivatives 3, 4’, 5-tri (benzoyloxy) stilbene, 3, 4’, 5-tri (toluyloxy) 
stilbene and 3, 4’, 5-tri (2”-butenoyloxy) stilbene have been synthesized by esterification process 
that can further be subjected for biological evaluation. Structures and purities of all newly 
synthesized derivatives were confirmed by 1H, 13C NMR spectroscopy and infrared 
spectroscopy. 
 
 
 
 
 
 
3 
 
DEDICATION 
In loving memory of my late grandmother, Chandra Kala Pageni 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 
 
                                                    ACKNOWLEDGMENTS 
I would like to express my deepest appreciation to Dr. Yu-Lin Jiang and Dr. Cassandra 
Eagle for the mentorship and guidance during the research. I am grateful to my committee 
members, Dr. Aleksey Vasiliev and Dr. Ismail Kady. Huge thanks to Dr. Ray Mohseni, Dr. 
Marina Roginskaya, and Jillian Quirante for all the help and support during the graduate studies.  
 I would also like to thank my parents for their support and unconditional love. I would 
not be here without their sacrifices. I am also grateful to my brother-in-law, Keshav Prasad 
Bagale, for his support and valuable suggestions over the years. Special thanks to my sisters 
Srijana, Pratima, Nagina, and Archana who helped me to become who I am. Further I would like 
to convey my sincere thanks to Dan Ressler, Darcy Clawson, BozumehSom, KoladoOjo, Marian 
Osei – Mensah, Joel Cowan,KiranPhuyal, DenishPiya, NiranjanGhimire, Kamal Kafle, 
DandaPaniChapagai, and JwalantaShrestha.  
My appreciation goes to all the faculty and staff of chemistry department for all the co-
operation and help. Lastly, I would like to thank all my family and friends for their love and 
support.  
 
 
 
 
 
 
5 
 
TABLE OF CONTENTS 
            Page 
ABSTRACT………………………………………………………………………… .................... 2 
DEDICATION ................................................................................................................................ 3 
ACKNOWLEDGEMENTS ............................................................................................................ 4 
LIST OF SCHEMES....................................................................................................................... 9 
LIST OF FIGURES ...................................................................................................................... 10 
LIST OF ABBREVIATION ......................................................................................................... 11 
Chapter 
1. INTRODUCTION ................................................................................................................. 12 
Cancer ........................................................................................................................................... 13 
Types of Cancer ..................................................................................................................... 13 
Causes of Cancer ................................................................................................................... 14 
Prevention of Cancer ............................................................................................................. 15 
Treatment of Cancer .............................................................................................................. 16 
Surgery .................................................................................................................................. 16 
Chemotherapy ....................................................................................................................... 16 
Radiation Therapy ................................................................................................................. 17 
Immunotherapy ..................................................................................................................... 18 
6 
 
Hyperthermia ......................................................................................................................... 19 
Antioxidants .................................................................................................................................. 19 
Natural Compounds with Health Benefits ............................................................................................ 21  
Polyphenols and Its Classifications ....................................................................................................... 23 
Flavanoids as Anti-Cancer Compounds ................................................................................................ 24 
Anthraquinones and Napthaquinones .................................................................................................... 25 
Stilbene ......................................................................................................................................... 25 
Derivatives of Stilbene .......................................................................................................... 26 
Pterostilbene .......................................................................................................................... 26 
Piceatannol ............................................................................................................................ 27 
Pinosylvin .............................................................................................................................. 28 
Resveratrol ............................................................................................................................. 28 
Nomenclature ......................................................................................................................... 29 
Physical and Chemical Properties ......................................................................................... 30 
Resveratrol as a Cancer Drug ................................................................................................ 32 
Pharmokinetics of Resveratrol............................................................................................... 33 
Biological Synthesis of Resveratrol ...................................................................................... 34 
Chemical Synthesis of Resveratrol ........................................................................................ 35 
Derivatives of Resveratrol ..................................................................................................... 36 
Drawbacks of Resveratrol ..................................................................................................... 39 
7 
 
Objectives of Research ................................................................................................................. 39 
Synthesis Design ........................................................................................................................... 40 
Proposed Synthetic Pathway for Compound 1 ..................................................................................... 40 
Proposed Synthetic Pathway for Compound 2 ..................................................................................... 41 
Proposed Synthetic Pathway for Compound 3 ..................................................................................... 42 
2.  RESULTS AND DISCUSSION .............................................................................................. 43 
Synthesis of 3, 4’, 5- tri(benzyloxy)stilbene ......................................................................................... 43 
Synthesis of 3, 4’, 5- tri(toluyloxy)stilbene .......................................................................................... 44 
Synthesis of 3, 4’, 5- tri(2”- butenoyl)stilbene ..................................................................................... 45 
Conclusions ................................................................................................................................... 46 
3. EXPERIMENTAL .................................................................................................................... 49 
General Methods ........................................................................................................................... 49 
Experimental Procedures .............................................................................................................. 50 
Synthesis of 3, 4’, 5- tri(benzyloxy)stilbene ......................................................................................... 50 
Synthesis of 3, 4’, 5- tri(toluyloxy)stilbene .......................................................................................... 50 
Synthesis of 3, 4’, 5- tri(2”- butenoyloxy)stilbene .............................................................................. 51 
REFERENCES ............................................................................................................................. 52 
APPENDICES .............................................................................................................................. 58 
APPENDIX A: 1H NMR Spectrum of Compound 1 in CDCl3 ................................................ 58 
APPENDIX B: 13C NMR Spectrum of Compound 1 in CDCl3 .............................................. 59 
8 
 
APPENDIX C: IR Spectrum of Compound 1 .............................................................................. 60 
APPENDIX D: 1H NMR Spectrum of Compound 2 in CDCl3 ................................................ 61 
APPENDIX E: IR Spectrum of Compound 2 .............................................................................. 62 
APPENDIX F: 1H NMR Spectrum of Compound 3 in CDCl3 ................................................. 63 
APPENDIX G: IR Spectrum of Compound 3 .............................................................................. 64 
APPENDIX H: 1H NMR Spectrum of RV in DMSO ................................................................ 65  
VITA ..................................................................................................................................... 66 
 
 
 
 
 
 
 
 
 
 
 
9 
 
LIST OF SCHEMES 
Scheme           Page 
1. Reaction of Oxidants with Radicals.……………………………………………………..20 
2. Stable Resonance form of Butylated Hydroxy Anisole.………………………………....21 
3. Resonance Structure of Proton Abstraction at Para Position.…………………………....31 
4. Resonance Structure of Proton Abstraction at Meta Position.…………………………...31 
5. Biosynthesis of Resveratrol.…………………………………………………………......35 
6. Synthesis of RV Using Sequential Heck Reaction .……………………………………..35 
7. Resveratrol Synthesis by Mingfu Wang et al.…………………………………………...36 
8. Synthesis of Resveratrol Triester by Esterification.………………………….………….40 
9. Synthesis of 3, 4’, 5-tri(benzoyloxy)stilbene.……………………………………………41 
10. Mechanism of Esterification of Resveratrol  .…………………………………………...41 
11. Synthesis of 3, 4’, 5-tri(toluyloxy)stilbene.…………………………………….………..42 
12. Synthesis of 3, 4’, 5-tri(2”-butenoyloxy)stilbene.……………………………………….42 
13. Future Reactions of the New Triesters .…………………………………………………47 
 
 
 
 
 
 
10 
 
LIST OF FIGURES 
Figure            Page 
1. Classification of Polyphenols.………………………………………………….………..24 
2. Flavone Structure.……………………………………………………………….……….24 
3. Structures of Anthraquinones and Napthaquinones.…………………………….……….25 
4. Structures of Cis and Trans Stilbene.…………………………………………….………26 
5. Structure of Pterostilbene.……………………………………………………….……….27 
6. Structure of Piceatannol.…………………………………………………………………27 
7. Structure of Pinosylvin.………………………………………………………………….28 
8. Structure of Resornicol.………………………………………………………………….29 
9. Structure of Resveratrol.………………………………………………………………....29 
10. Structure of Cis and Trans Resveratrol.………………………………………………….30 
11. Methoxylated Derivatives of Resveratrol.……………………………………………….37 
12. Hyrdoxylated Derivatives of Resveratrol.……………………………………………….37 
13. Miscellaneous Derivatives of Resveratrol.……………………………………………....38 
14. Derivatives by Jiang.…………………………………………………………….……….39 
 
 
 
 
 
11 
 
LIST OF ABBREVIATIONS 
DNA             Deoxyribonucleic Acid 
RNA       Ribonucleic Acid 
Fig      Figure 
UV      Ultraviolet 
Rf      Retention Factor 
Hrs      Hours 
Rpm      Rounds per minute 
Temp      Temperature 
M.p      Melting Point 
B.p      Boiling Point 
IR      Infrared 
TMS      Tetramethylsilane 
THF      Tetrahydrofuran 
TEA      Triethyl Amine 
Ph3P      Triphenylphosphine 
NMR      Nuclear Magnetic Resonance 
12 
 
CHAPTER 1 
INTRODUCTION 
With the advent of science and technology, there has been vast improvement in the field 
of health science. Medical conditions that were considered fatal and untreatable are no more 
threat for mankind. Just in US alone the average expectancy age has increased from 50 at early 
1900s to almost 80 in 2000
1
.  This improvement is only possible with the discovery of new drugs 
and better medical facilities.  A lot of these drugs actually have been discovered from the plant 
and natural sources after a long research
2
. Among the compounds with a discovery origin to 
plants is resveratrol (RV). Resveratrol is a natural polyphenol that is primarily found in berries, 
peanuts, grape skin, and red wine. It is also a phytoalexin produced by plants in response to 
stress, injury, fungal attack, and UV radiation. It has been into media attention lately for its 
various health benefits. It has been found to exhibit anti-inflammatory, anti-cancer, anti-oxidant, 
anti-aging, antiobesity, and neuroprotective properties. As a phytoestrogen, it can provide 
cardiovascular protection. Its uses have also been linked with the metabolism of lipids, oxidation 
of low-density lipoproteins and aggregation of platelets 
3
. Resveratrol was found to inhibit the 
initiation, promotion and progression stages of cancer displaying the chemo preventive effects 
4
. 
Currently, resveratrol is in clinical phase II trials as anti-cancer drug for human colon cancer 
5
.  
In vivo experiments conducted in rodents show evidence of positive effects in controlling stress 
and disease in rodent models 
6
.  However, the solubility and bioavailability of resveratrol is very 
low so higher concentrations should be administered to see any therapeutic effects in the body. 
To overcome the setback, efforts have been made to synthesize water soluble derivative. The 
new derivative with new increased solubility and bioavailability will be promising tools as 
13 
 
cancer chemo preventive agents, as well as cancer therapeutics in the prevention and treatment of 
cancer.  
Cancer 
Cancer is the second leading cause of deaths in western countries after heart disease. In 
US alone more than one million people are diagnosed with cancer annually and more than half 
result in death. Cancer is a medical condition where abnormal cells in body divide without any 
control. Cancer cells do not respond normally to the body’s control mechanism, so they divide 
excessively and invade the neighboring tissues. If cancer cells are provided with the nutrition 
they need, they can divide indefinitely. An experiment was done to prove the immortality of 
cancer cell. HeLa cells, cancer cells taken from a woman named Henrietta Lacks, have been 
reproducing in culture since 1951
6
. Cancer starts when a normal cell in the body converts to a 
cancer cell through the process of transformation. A transformed cell is instantly detected by 
body’s immune system. However, if it manages to evade, it may proliferate and form a mass of 
abnormal cells called tumor. If the abnormal cells remain at the original site, it will result in the 
less severe condition termed as benign tumor. Benign tumor can be completely removed by 
surgery and pose little threat. Malignant tumors have capability to enter the bloodstream 
invading other tissues and disrupting the normal function of various systems in the body. They 
are difficult to treat and may become life threatening. Cancer cells can spread to distant locations 
from the original site by a process called metastasis.  
Types of Cancer 
Cancers are named according to the type of tissue in which cancer originates i.e. 
histological type and contains suffix to represent the site
6-8
. Below are the five broad groups to 
classify the cancer. 
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1. Carcinomas consist of the cancer that originates at the cells that cover internal and 
external parts of body. It can further be divided into two major subtypes: 
adenocarcinoma, which develops in an organ or gland, and squamous cell carcinoma, 
which originates in the squamous epithelium. Most carcinomas affect organs or glands 
capable of secretion, such as the breasts, which produce milk, or the lungs, which secrete 
mucus, or colon or prostate or bladder. 
2. Sarcoma refers to cancer that originates in supportive and connective tissues such as 
bones, tendons, cartilage, muscle, and fat. The most common sarcoma usually invades the 
bone creating a massive pain.  
3. Lymphomas are cancers that initiate in the immune system tissues like lymph nodes. 
4. Leukemias are cancers that begin in the bone marrow and often accumulate in the blood 
stream.  
5. Adenomas are the cancers that arise in the glandular tissues. Cancer in glands like 
thyroid, pituitary, and adrenal falls into this category.  
Causes of Cancer 
Normal cells in the body follow a path of growth, division, and death. After a certain 
number of divisions a cell is programmed to die called apoptosis, and when the cell ceases to die 
cancer begins to form. Cancer cells do not experience programmatic death and instead continue 
to divide. This abnormal behavior of cells is the result of mutation in regulatory genes. Genes are 
the instructions that tell cells what to do and are made up of DNA. So, the cancer occurs when 
there are changes in the DNA of a cell. These changes may be either inherited genetically from 
parents or caused by environmental factors. The various factors that can cause the damage on 
DNA to lead cancer are listed below.  
15 
 
▪ Carcinogens: Any substance that is capable of developing cancer is known as a carcinogen. The 
carcinogen changes the structure of DNA resulting in a mutation that finally leads to cancer. 
Commonly known carcinogens include asbestos, arsenic, benzene, bisphenolA (BPA), pesticides, 
dioxins, UV radiation, polybrominateddiphenylethers (PBDEs), tobacco smoke, and polycyclic 
aromatic hydrocarbons (PAHs) 
▪ Age: The chances of developing cancer increase with age even though it can occur at any age. 
A survey shows more than three out of five people who get cancer are over the age of 65, and 
more than a third are over 75
7
. 
▪ Lifestyle: Some of the choices in life such as excessive drinking and smoking increase the risk 
of developing cancer.  
▪ Nutrition: Diets of processed food and red meat are more likely to result in cancer than diets of 
fruits and vegetables. Poor diets choices that often lead to obesity have been linked to breast, 
womb, and kidney cancer. 
▪Immune System: People with poor immune systems are found to have developed certain forms 
of cancer like lymphomas. 
▪Viruses and Bacteria: These microbes can cause the damages to the cell making them more 
prone to cancer. Human Papilloma Virus (HPV) is linked with developing cancer on cervix, anal, 
or genital area. 
Prevention of Cancer 
Decades of research revealed that cancer is easier to prevent than to treat. There is not a 
single factor that leads to cancer. There are multiple things in our genes, lifestyle,  and the 
peripheral environment that determine the risk of developing cancer. So, any step taken to 
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decrease the chances of developing cancer is called cancer prevention. The following measures 
can be taken to reduce the risk of cancer: no use of tobacco, healthy diet, physical activities to 
keep a healthy weight, less exposure to sun, immunization against viruses and bacteria, safe 
health practices, and regular medical checkup. 
Treatment of Cancer 
There options for cancer treatment is not limited to single rather a range of options are 
available. The best option is determined by various factors like age, history, and lifestyle. More 
often various types of treatment are combined to get the best possible result. The most popular 
types of cancer treatment are discussed below. 
Surgery 
Surgery is a common and oldest technique to treat or even help prevent cancer. The first 
use of this technique was employed by ancient Egyptians to remove breast tumors in 7
th
 century. 
If the cancer is benign, it offers the biggest chance for cure as the tumor does not get a chance to 
spread around the body. However, if the cancer has metastasized, surgery won’t be very 
beneficial.  Some type of surgery is usually performed in most people with cancer. The 
symptoms of bowel obstruction or spinal cord compression can be controlled by surgery
9
.  
Chemotherapy 
Chemotherapy is the use of chemicals to kill the cancer cells or stop them from growing. 
The chemicals interferes the process of cell division by either damaging the RNA or DNA. 
Chemotherapy is primarily used to damage the DNA of the affected cancer cells, stop the cell 
from replicating by inhibiting by inhibiting the synthesis of new DNA strand, and stop the 
division of original cell into its daughter cells in mitotic phase of cell division. The drugs for 
chemotherapy are given in combination of two or three at the same time. These combinations are 
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called regimens. The purpose of regimens differs according to the stage of cancer. For instance, 
regimens lower the risk of cancer coming back in early stage breast cancer, while it makes 
cancer shrink or disappear in advanced stage. Chemo therapy not only kills the cancer cells but 
affects the healthy cells. Damage in the blood cells results in anemia, fatigue, and various kinds 
of infections.  Mouth sores and diarrhea are caused by the damage in the cell at mucous 
membrane.  Another common side effect of chemo therapy is the destruction of cells at hair roots 
and follicles that ultimately results in loss of hair. The cytotoxic chemotherapy drugs have 
different method of killing cancer cells. They are classified accordingly to following classes: 
alkylating agents, heavy metals, antimetabolites, anthracycline, antibiotics, epipodophyllotoxins, 
plant alkaloids, and antitumor antibiotics.  
Radiation Therapy 
In radiation therapy, high energy particles are used to damage the cancerous cells in the 
body. The common types of radiation used are X-rays, gamma rays, and charged particles. If the 
radiation is delivered by a machine outside the body, it is known as external-beam radiation 
therapy and if the radiation is delivered from radioactive material placed inside the body near 
cancer calls, it is called brachytherapy or internal radiation therapy. The radiation either damages 
DNA directly or it creates free radicals inside the cell that actually end up damaging the DNA. 
Once the DNA is damaged, cancer cells stop dividing and eventually die and will be eliminated 
by body’s natural processes.  
Targeted Therapy 
Targeted therapy is a selective way of attacking the cancer cells with drugs or other 
substances. It is a newer type of treatment and is precise and does very little damage to normal 
cells. It interferes with the proliferation and spread of cancer cells. This form of therapy mainly 
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focus on proteins that are involved in cell signaling pathways regulating the basic cellular 
functions and activities like cell division, cell movement, cell responses, and cell death. When 
the signals to divide and grow uncontrollably are blocked, the progression of cancer is halted and 
may even induce death of the cancer cell through a process called apoptosis. Small-molecule 
drugs or monoclonal antibodies are the most common targeted therapies. It is convenient for 
small-molecule drugs to diffuse into the cell to act on the specific targets. Monoclonal antibodies 
are directed against the targets outside the cell because they cannot penetrate the plasma 
membrane. In case of chronic myeloid leukemia (CML), BCR-ABL gene is responsible to relay 
the signal regulating cell proliferation. Continuous proliferation of CML cells can be controlled 
by targeting BCR-ABL using targeted therapy. In contrast to traditional chemotherapy, targeted 
therapies are generally better tolerated, but they are associated with several adverse effects, such 
as acneiform rash, cardiac dysfunction, thrombosis, hypertension, and proteinuria
10
. 
Immunotherapy 
Immunotherapy is a new type of therapy to fight against various types of cancers where 
body uses own immune system to help fight cancer. The immune system is a group of cells and 
organs that work together to defend the body against foreign particles such as cancer cells, 
bacteria, and viruses. The defense mechanism is known as immune response where several kinds 
of cells like macrophages, lymphocytes, T lymphocytes, dendritic cells, and granulocytes go into 
action after the entry of foreign particles.  These immune cells communicate with each other by a 
number of special protein molecules known as cytokines. Cytokines can be natural, recombinant, 
or synthetic. Some of the cytokines are interferons, interleukins, tumor necrosis, and colony-
stimulating factors
6-8
. The idea of immunotherapy treatment involves giving larger amounts of 
proteins either by an injection or infusion so that the cells of immune system acts more 
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effectively to make tumor cells more prominent to the immune system. The active agents of 
immunotherapy are termed as immunomodulators. Flu, chills, fever, nausea, fatigue, and loss of 
appetite are some of the common side effects of this type of therapy. 
Hyperthermia 
Hyperthermia is a type of cancer treatment in which the temperature of tumor-loaded 
tissue is raised up to 113°F. The applied high temperature is capable of killing the cancer cells 
with minimal injury to normal cells. It is applied as an adjoining therapy with other established 
cancer treatments like radiotherapy and chemotherapy. With the use of this form of treatment, 
cancer cells becomes more sensitive to radiation that otherwise would resist radiation. Heat is 
applied by using microwave, radiofrequency, and ultrasound to a small specific area such as 
tumor in the case of local hyperthermia.  Metastatic cancer that has spread throughout body is 
treated by using whole-body hyperthermia by raising the body temperature to 107-108°F using 
thermal chambers 
11
.  
Antioxidants 
In general sense, any substances that slow down or prevent the oxidation of other 
compounds are known as antioxidants. Chemically, antioxidants are compounds that have 
capability to act as an electron donor. This property is particularly important as they can stabilize 
or deactivate free radicals. A free radical is a species that contains one or more unpaired 
electrons and are electron-deficient. These are very reactive as they have unsatisfied electron 
valence pair and can be produced in both normal and pathological processes. Free radical 
represents reactive oxygen species (ROS) such as hydroxyl radical, the superoxide anion radical, 
hydrogen peroxide, nitric oxide radical, singlet oxygen, and various lipid peroxides. All of these 
species are capable to react with membrane lipids, nucleic acids, proteins, and enzymes resulting 
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in cellular damage. Aging, atherosclerosis, cancer, pulmonary dysfunction, Parkinson’s disease, 
renal diseases, and neonatal lipoprotein oxidation are some of the effects of reactions initiated by 
free radicals. There are numerous pathways for the generation of ROS inside the body but 
following are the common ones. 
▪ Result of normal aerobic metabolism: Most of the oxygen in the human body gets 
consumed by the mitochondrial electron chain transport but some manage to escape to 
form free radicals. 
▪ Consequence of oxidative burst from phagocytes in the process of defense mechanism 
against foreign particles including bacteria and viruses. 
▪Product of xenobiotic metabolism, detoxification, of toxic substances  
Antioxidants terminate the chain reactions by removing free radical intermediate and 
inhibit other oxidation reactions. They do this by being oxidized themselves, so antioxidants are 
often reducing agents such as thiols, ascorbic acid, or polyphenols.  
R●       +   AH   →   RH    + A● 
RO●    +   AH   →   ROH + A● 
ROO● +   AH   →   ROOH + A●  
R●  +      A●      →    RA 
RO●  +      A●      →    ROA 
ROO●  +      A●      →    ROOA  
Antioxidant + O2   →   Oxidized Antioxidant 
Scheme 1. Reaction of Oxidants with Radicals 
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There are two kinds of antioxidants: Natural and Synthetic antioxidants. The examples of 
natural antioxidants are tocopherols, nordihydroguaretic acid (NDGA), sesamol, and gossypol. 
Some of the synthetic antioxidants are butylated hydroxyl anisole (BHA), butylated hydroxyl 
toluene (BHT), propyl gallate (PG), and tertiary butyl hydroquinone (TBHQ).Most of the 
antioxidants currently in use are monohydroxy or polyhydroxy phenol compounds with different 
ring substituents. They have low activation energy to donate hydrogen and the resulting 
antioxidant free radical does not initiate another free radical due to the delocalization of radical 
electron as shown in Scheme 2. The resulting antioxidant free radical is quite stable so does not 
undergo rapid oxidation.  
 
Scheme 2. Stable Resonance Form of BHA 
Natural Compounds with Health Benefits 
The search for possible therapeutic drugs for cancer is ongoing on natural sources like 
plants, animals, marine organism, or microorganism. A recent report indicates that medicinal 
plants are used by 80% of people living in the rural areas of developing countries where the 
primary health care is inadequate
14
. Plants have always been used as sources of medicinal agents 
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since the beginning of mankind. The chemical and biological diversity found in nature has 
always been an indispensable resource for the development of novel anti-cancer compounds. The 
quest has been assisted by the improvement in technology like structure elucidation and organic 
synthesis. It is estimated that about 100 natural products have been included in treatment of 
various forms of tumor during the last five decades of research 
13
. Plant derived anticancer agents 
represents just about one-fourth of the total treatment options at present. In US, nine compounds 
originating from plants have been approved for use in cancer therapy since 1961. The agents are 
vinblastine, vincristine, navelbine, etoposide, teniposide, taxol, taxotere, topotecan, and 
irinotecan. Another 11 agents are 10-hydroxycamptothecin, (-)-sophocarpine, monocrotaline, d-
tetrandrine, lycobetaine, indirubin, colchicinamide, curcumol, curdione, gossypol, and 
homoharringtonine. For instance, vinblastine and vincristine, natural alkaloids found in 
Catharanthusroseus or Vincarosea, are used as drugs in the treatment of lymphoma and leukemia 
respectively. It has been found different plants contain different bioactive compounds that 
depend on the area, climate, and the mode of agriculture. The main challenge for the anti-cancer 
drug is the re-establishment of apoptosis and some plant products have been found to induce 
apoptosis.  A significant progress has made using this particular capability of plant products. 
Vinca alkaloids that were isolated from Catharanthusroseus is an example of successful 
anticancer plant product. These compounds bind to tubulin and disrupt the mitotic assembly in 
course of cell division
15
. Another example is taxol, an extract from the bark of Taxusbrevifolia. It 
has the cytotoxic capability that is mediated by the stabilization of microtubules
16
.  
 
 
 
23 
 
Polyphenols and Its Classification 
Compounds that have more than one phenolic hydroxyl group attached to one or more 
benzene rings are known as polyphenol as shown in Fig 1. It is one of the most numerous and 
ubiquitous group of plant metabolites that can range from a simple phenolic molecule to highly 
polymerized compounds. The interests in polyphenols have recently surged because of the anti-
cancer properties. The anti- cancer properties of polyphenols can be attributed to their ability to 
act as anti-oxidants, and also to their ability to interact with basic cellular mechanisms. Free 
radical scavenging and metal chelating are the modes of action to act as an antioxidant. The 
chain-breaking ability of polyphenols is attributed to the ease of donation of the phenolic H-atom 
to the attacking free radical. Fruits and vegetables are rich sources of polyphenols so the regular 
consumption of food with polyphenols significantly reduces the risk of various types of cancer. 
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Fig 1. Classification of Polyphenols 
Flavanoids as Anti-Cancer Compounds 
Another class of natural compounds that show anti-cancer activity is flavanoids. The 
structure is shown in Fig 2.  It is abundantly found in plants and vegetables and has been linked 
to reducing the risk of chronic diseases including cancer. At least 4000 distinct types have been 
found. Many flavonoids are found to have antioxidative activity, free-radical scavenging 
capacity, and coronary heart disease prevention along with anti-cancer activity. It is categorized 
as a chemo preventive substance that has been found to either delay or reverse the process of 
carcinogenesis. The mechanism involved during the course of action may be divided as blocking 
effects and suppressing effects. Flavanoids can regulate P-glycoprotein (Pgp), the MDR 
(multidrug-resistance) protein that plays a major role in overcoming the major hurdle, drug 
resistance
17
. Flavanoids have a major role in inhibiting various enzymes that are the targets in 
anticancer treatment, e.g. eukaryotic DNA topoisomerase I, Cox I and II, and estrogen 2- and 4-
hydroxylases
18
.  
 
Fig 2. Flavone Structure 
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Anthraquinonesand Napthaquinonesas Anti- Cancer Compounds 
Anthraquinone is a class of aromatic organic compound that contains two keto groups on 
the central ring as shown in Fig 3. Aloe emodin is one of the anthraquinones which inhibits cell 
growth in tumor of lung carcinoma, hepatoma, and leukemia. Aloe emodin particularly plays an 
important role in the regulation of cell-cycle progression and shows a high specificity for 
neuroectodermal tumor cells. Other anthraquinones like emodin and rhein were liked with G1/S 
cell-cycle arrest in hepatoma, glioma, and colon carcinoma cells
19
.  
Napthaquinone usually refers to organic compound derived from naphthalene. Juglone is 
the most studied napthaquinone known for its anti-bacterial, anti-fungal, and anti-viral 
properties. Its ability to induce apoptosis in the tumor cell marks juglone as an anti-cancer 
compound. 
 
Fig 3. Structures of Anthraquinones and Napthaquinones 
Stilbene 
The name stilbene was derived from a Greek word stilbos, which means shining. Stilbene 
is a highly conjugated compound and named 1, 2-diphenylethylene. There are two isomeric 
forms of stilbene shown in Fig 4: (E)-stilbene also known as trans-stilbene and (Z)-stilbene also 
known as cis-stilbene. The sterical interaction of phenyl rings forces them out of plane and 
prevents conjugation making the cis isomer thermodynamically less stable.  (E)-stilbene has a 
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melting point of 125°C, while the melting point of Z isomer is around 6°C20. Under the exposure 
to light, trans-stilbene can isomerizes to cis-stilbene using the features associated with absorption 
and fluorescent properties. During the process, the excitation of π- electrons of the conjugated 
ethenediyl group occurs to π* orbitals. Thus, excited singlet state is governed by fluorescence 
from the S1state competing with isomerization. The process of photochromism, trans-
cisphotoisomerization of stilbene derivatives, can be observed easily by a single steady-state 
fluorescence technique
20
.  
 
Fig 4. Structure of Cis and Trans Stilbene 
Derivatives of Stilbene 
Synthesis of stilbene derivative is fairly simple as the derivatives are usually thermally 
and chemically stable. They exhibit absorption and fluorescence properties that can be monitored 
by various optical techniques. The derivatives of stilbene are primarily used for various 
industrial, photophysical, photo chemical, and biomedical research purposes. Stilbenoids, 
hydroxylated derivatives of stilbene, are the secondary products of heartwood formation of trees 
that can also act as phytoalexins
21
. 
Pterostilbene 
Researchers have found that pterostilbene (Fig 5) and resveratrol works in a synergistic 
fashion for various beneficial functions in the human body. For example, both the compounds 
activate one’s “longevity genes” and pterostilbene assists in gene expression in a way that 
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increases the effects produced by resveratrol
21-23
. Rimando and researchers at University of 
Illinois at Chicago made a huge discovery in 2002 about the anti-cancer properties after the tests 
in rats’ mammary glands22.  
 
Fig 5. Structure of Pterostilbene 
Piceatannol 
Piceatannol is a naturally occurring hydroxylated analogue of resveratrol that shows wide 
spectrum of biological activity (Fig 6). Piceatannol has been found in grapes, passion fruit, white 
tea, and Japanese knotweed and has antioxidative and anticancer properties.  In addition, 
piceatannol is found to be involved in the suppression of the activation of some transcription 
factors like NF-kappaB that plays a major role as a transcriptional regulator in response to the 
cellular stress caused by free radicals, UV radiation, cytokines and microbes
24
.Piceatannol has 
been found to either delay or inhibit the process of adipogenesis indicating its use against 
obesity
25, 26
.  
 
Fig 6. Structure of Piceatannol 
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Pinosylvin 
Pinosylvin is another hydroxyl stilbene that lacks a hydroxyl group on the second ring as 
shown in Fig 7. The absence is accounted by its origin as a product of condensation of malonyl-
CoA and cinnamoyl-CoA instead of p-coumaroyl CoA. Unlike phytoalexins, pinosylvinis 
produced before the infection and are called pre-infectious stilbenoid. Pinosylvin is found in 
thePinusspecies.Pinosylvin has been found to exhibit anti-apoptotic effect
27
and a suitable 
candidate to act as a pro-angiogenic factor
27
.  
 
Fig 7. Structure of Pinsosylvin 
Resveratrol 
Resveratrol is a naturally occurring phytoalexin produced by plants in response to stress, 
UV radiation, and fungal attack. RV is found in grapes, wine, peanuts, blueberries, cranberries, 
mulberries, and jack fruit. RV has also been found in seeds, roots, vines, and stalk but the highest 
concentration is found on the skin which is 50-100 µg per gram. It is interesting to note that on 
average around 73 µg of RV in found in peanuts while 160 µg on an ounce of red wine. RV was 
first discovered in 1940 as an off-white powder from the extract of roots of white hellebore lily 
(Veratumgrandiflorum). It was considered a resorcinol (Fig 8) derivative coming from a veratum 
species so was named resveratrol. Dried roots of white hellebore and Japanese knotweed 
(Polygonumcuspidatum) were found to have RV and were used to treat various skin infections 
like athlete’s foot.  
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Fig 8. Structure of Resorcinol 
Nomenclature 
According to IUPAC nomenclature, RV is named as trans-3, 4’, 5-trihydroxystilbene (Fig 
9). The structural formula and numbering of carbon is shown below. Some other names used for 
RV are 3, 4’, 5-Stilbenetriol, (E)-5-(p-Hydroxystyryl) resorcinol and (E)-5-(4-hydroxystyryl) 
benzene-1, 3-diol. 
    
Fig 9. Structural Formula of RV 
France has one of the lowest rates of cardiovascular disease (CVD) rates in the world
31
. 
According to a report by World Health Organization 2009 Mortality Database, the deaths from 
cardiovascular disease (CVD) for French population were 50 out of every 100,000, while it was 
129 for American counterparts
31
.  It was really surprising to see the low rates despite the intake 
of high cholesterol and saturated fats in French diet. It led to a phenomenon known as French 
Paradox that attributes the lower incidence of coronary diseases for regular consumption of red 
wine, a major source of RV. The term “French Paradox” was first coined by Serge Renaud in 
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1993 in an effort to explain the low rates of CVD in France on the basis of red wine 
consumption
31, 32
.  
Chemical and Physical Properties 
RV exists as white powder with slight yellow cast in two geometric isomers (Fig 10): cis 
(Z) or trans (E). The Z isomer is sterically hindered and less stable because the steric interactions 
forces the aromatic rings out of plane and prevent conjugation.The trans form can isomerize to 
give cis-form in presence of UV radiation by a process called photo isomerization. 
 
  Fig 10: Structure of Cis-RV and Trans-RV 
RV is a fat soluble compound and has very limited solubility in water. The solubility of 
RV in water is 0.03g/L while the solubility in ethanol and DMSO are 50g/L and 16g/L 
respectively. RV behaves in a similar manner to phenol when reacting with other 
chemical species as it a polyphenol. The stilbene skeleton is stable and the reactivity is 
associated with the hydroxyl functional group of phenol units. RV is a good radical 
scavenger through electron capture or proton donation to convert free radicals to more 
stable molecules. The hydroxyl group at 3 and 5-position (Fig 10) are equivalent because 
of the rotation of the sigma bond between carbon-1 and SP
2
 hybridized carbon. The 
hydroxyl group at 4’-position (para) is more acidic than the ones at 3 and 5-position 
(meta). This is accounted by the stabilizing effect caused by the delocalization of 
electrons over a greater area resulting in more resonance structures. The formation 
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resonance structure for para and meta hydrogen abstraction is shown below in Scheme 3 
and Scheme 4 respectively.  
 
Scheme 3. Resonance Structures from Proton Abstraction at Para Position
50
 
 
Scheme 4. Resonance Structures from Proton Abstraction at Meta Position
50
. 
 
Biological Activities 
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RV has been reported to exhibit a wide range of biological and pharmacological 
properties that are beneficial for human health like anti-inflammatory
33-35
, antioxidant
33-36
, 
antiproliferative
34
, proapoptotic
33
, antiaging
34
, cardioprotective
33-36
, anticancer
33-36
, 
neuroprotective
34, 35
 , and antiviral properties
33-36
. It has also been speculated RV can promote 
nitric oxide production
33-36
, inhibit platelet aggregation
33-36
 , and increase high-density 
lipoprotein cholesterol to serve as a cardioprotective agent
33-36
. Recently, RV has been identifies 
as a sirtuin-activating compound
33
. Sirtuins are a conserved family of NAD+-dependent 
deacetylases (class III histone deacetylases). Like SIRT1, small-molecule activators of sirtuins 
including resveratrol extend lifespan in yeast and higher organisms
33
. It has also been reported 
RV has potential inhibitory effects on cyclooxygenase
36
, rat liver mitochondrial ATPase
36
, 
human F1 ATP-ase
36
, and tyrosinase
36
.  It has been that there is a close relationship between the 
process of aging and the onset of neurological disorders so an ideal compound to fight against 
the neurological disorder should have neuroprotective action and anti-aging effect. RV has both 
the properties and is a suitable candidate for the treatment of neurological disorders like 
Parkinson’s and Alzheimer’s39. According to European Journal of Pharmacology, RV has 
important anti-inflammatory neuroprotective effects on animal models with Parkinson’s disease. 
RV has been found to have a capability to prevent “free-radical-mediated damage of nerve cells” 
39 that further assists in overcoming the damage caused by deep brain stimulation
39
.  
Resveratrol as a Cancer Drug 
Hundreds of plant extracts were evaluated to find chemical agents that inhibit cancer.  
Resveratrol was discovered as a result of search for chemo preventive agents
37
. 
Chemoprevention is the prevention of cancer by administering chemical agents that reduce the 
risk of carcinogenesis. Some of the examples of agents are nonsteroidal anti-inflammatory drugs 
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(NSAIDS) that include indomethacin, aspirin, piroxicam, and sulindac
37, 38
. The primary function 
of these agents is to inhibit cyclooxygenase (COX)
 37
. This inhibition is significant in course of 
chemoprevention as COX catalyzes the substances that induce tumor growth and suppress 
immune surveillance. RV is currently in clinical phase II trial as an anti-cancer drug for the cure 
of human colon cancer
36
. In mice RV has been found to selectively suppress the transcriptional 
activation of acytochrome P-450 1A1 that further inhibits the formation of carcinogen-induced 
preneoplastic lesions. Some compounds turn into carcinogenic after they have been metabolized 
by enzymes like cytochrome P450. RV actually inhibits the function of certain cytochrome P450 
which would be instrumental in reducing the exposure to the activated carcinogens. RV also 
stimulates apoptosis, cell cycle delay or a block in G1→S1 transition phase at cellular level
38
.RV 
has been found not only to inhibit the proliferation of cancer cells but also induce apoptosis in 
various cancer cell lines. Another significant role played by RV against cancer is the inhibition 
of metalloproteinase, an enzyme that helps the cancerous cells to invade normal tissue.  
Pharmokinetics of Resveratrol 
In spite of the therapeutic effects, pharmacokinetic properties of RV are not favorable. 
This is mainly because of poor bioavailability and rapid metabolization to glucuronide and 
sulfate conjugates. The plasma concentration of RV after the oral administration was found to be 
very low. In a study, RV was administered orally for 14 consecutive days at 50 or 150 mg/kg/day 
and plasma concentrations of RV and metabolites were measured using HPLC mass 
spectrometer system
40
.  RV was found to be approximately 20 percent bioavailable
41
. In rodents, 
RV was found to be absorbed mainly in duodenum and has the same 20 percent bioavailability
40
.  
Majority of the absorbed RV was found in plasma as conjugated derivatives. The five distinct 
metabolites found were RV monosulfate, two isomeric forms of RV monoglucuronide, 
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dihydroresveratrolmonosulphate and dihydroresveratrol monoglucuronide
40, 41
. The modification 
into the glucuronide and sulphate reduces the permeability and helps in excretion that has been 
found to reduce the bioavailability of RV. To enhance the pharmacokinetics, drug delivery 
systems need to be developed to protect and stabilize resveratrol and to enhance its 
bioavailability. Another method could be the administration of resveratrol through buccal cavity.  
Biological Synthesis of Resveratrol 
As discussed earlier, RV is produced as a phytoalexin by plants as a defense against 
pathogen attack. RV is synthesized from p-coumaroyl-CoA and three molecules of malonyl-
CoA. Stilbene synthase is used as enzyme during the course of reaction and is not very specific 
because it has also capability to accept other CoA esters and aliphatic primers for polypeptide 
synthesis.  The stilbene synthase is a condensing enzyme that uses three sequential condensation 
reactions with malonyl-CoA. The terminal carboxyl group is lost towards the end of the reaction 
as carbon dioxide. Chalcone is also synthesized in a similar fashion but uses different enzyme 
called chalcone synthase. The process is shown on Scheme 5 below.  
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Scheme 5. Biosynthesis of Resveratrol 
Chemical Synthesis of Resveratrol 
It may not be quite feasible and economical to extract resveratrol from the natural sources 
all the time so various efforts have been made to synthesize in the laboratory. Some of the 
popular methods with a good yield are depicted below with reaction Scheme 6 and Scheme 7. 
 
Scheme 6.Synthesis of RV Using Sequential Heck Reaction 
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Scheme 7. Resveratrol Synthesis by Mingfu Wang et al
46
. 
Derivatives of Resveratrol 
Various attempts have been made to synthesize new derivatives of RV to improve its 
biological activities. Structure-activity is used to analyze information of various properties like 
anti-tumor by selective modification of stilbene scaffold of resveratrol. The substitution of 
hydroxyl groups of RV by methoxy groups has been found to significantly improve the cytotoxic 
activity. Various methoxylated analogs of RV have been made since and some of the examples 
are shown below in Fig 11. Tetramethoxy-trans-stilbene was found to be more powerful in 
inhibiting the growth of cancer cell lines like colon, prostate, and ovarian cancer cells
33
. 
37 
 
 
   Fig 11.Methoxylated Derivatives of Resveratrol 
Compounds formed by the introduction of hydroxyl groups in stilbene have shown more 
biological activities than RV. Both tetrahydroxy-trans-stilbene and hexahydroxy-trans-stilbene 
has been found to inhibit cell growth and induce apoptosis in higher extent than RV
33
, 
47
. They 
have also been found to cause cell-cycle arrest at S or G2/M-phase. Some of the hydroxyl 
derivatives of RV are shown below
47, 48 
in Fig 12. 
 
Fig 12.Hydroxylated Derivatives of Resveratrol 
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Acetylated derivatives of RV were found to enhance cellular uptake than the parent 
compound, RV. For example, resveratrol triacetate was found to be efficient in inducing cell-
cycle arrest at S-phase and increases uracil mediated inhibition of proliferation. Another ester 
derivative, digalloylresveratrol, was found to induce apoptosis and inhibit the transition from S 
to G2/M-phase of the cell cycle
47, 48
. It also helped in the inhibition of the growth of colon cancer 
cells
48
. Some of the acetylated derivatives are shown below in Fig 13. 
 
Fig 13. Miscellaneous Derivatives of Resveratrol 
In 2008, Jiang synthesized two RV aliphatic acids and their esters in an attempt to 
overcome the limitations of RV. The derivatives showed better solubility in pure water and 
phosphate buffer (pH 7)
36
. The binding affinity of new derivatives with human serum albumin 
was 41-fold improvement and was much better ligand
36
. The derivatives are shown in Fig 14.  
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Fig 14.Derivatives of RV by Jiang      
Drawbacks of RV 
RV has been reported to have a lot of benefits to human health but the in vivo biological 
effects are strongly reduced by its low bioavailability and solubility. Its bioavailability is very 
limited due to high metabolization when subjected in plasma. This is a hurdle to the development 
of possible therapeutic applications. Most of the research is done in cultured cells that are 
exposed to unmetabolized RV and are of higher concentration than the one in blood plasma so it 
is also not quite sure if RV reaches the proposed site of action when administered orally. A study 
was conducted by giving a 25 mg oral dose RV to six healthy human but a trace amounts of 
unchanged resveratrol (<5 ng/mL) was detected in plasma. Most of the oral dose was recovered 
in urine as metabolites
42-45
.  
Objective of this Research 
The main objective of this research was to synthesize new derivatives of RV to overcome 
its drawbacks i.e. low solubility and low bioavailability. The new derivatives are expected to 
show anti-cancer properties and thus be able to use as chemo preventive compounds. The initial 
plan was to synthesize triester derivatives and hydrolyze to form diester derivatives. However, 
the aim was changed and limited to the synthesis of triesters. Also, another purpose of the 
research was to carry out independent organic synthesis and structure elucidation of new 
derivatives by spectral analysis. 
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Synthetic Design 
The objective of the research was inspired by the derivatives reported by Jiang 
36
. Jiang 
reported the synthesis of new RV aliphatic acids and esters that was found to be much better 
ligand for human serum albumin than RV
36
. The design for this research was to add both 
aliphatic and aromatic chain in all hydroxyl groups through an esterification reaction resulting 
triesters and is shown in Scheme 8.  
 
Scheme 8.Synthesis of Resveratrol Triester by Esterification 
The proposed synthetic pathways for the compounds 1, 2, and 3 have been shown below 
respectively in Scheme 9, Scheme 11, and Scheme 12. Scheme 10 shows the reaction mechanism 
involved.  
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Proposed Synthetic Pathway for Synthesis of 3, 4’, 5-tri ( benzoyloxy) stilbene 
 
 
Scheme9: Synthesis of 3, 4’, 5- (benzoyloxy)stilbene 
 
Scheme 10. Mechanism of Esterification of Resveratrol 
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Proposed Synthetic Pathway for Synthesis of 3, 4’, 5- tri (toluyloxy) stilbene 
 
Scheme 11: Synthesis of 3, 4’, 5- tri(toluyloxy)stilbene 
Proposed Synthetic Pathway for Synthesis of 3, 4’, 5- tri (2”- butenoyloxy) Stilbene 
 
Scheme 12: Synthesis of 3, 4’, 5 –tri (2”-butenoyloxy) Stilbene 
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CHAPTER 2 
RESULTS AND DISCUSSION 
Synthesis of 3, 4’, 5- tri (benzoyloxy) stilbene 
 
A high yield of approximately 90% of compound 1was obtained as white solid after the 
purification using gradient column chromatography. The melting point of the compound 1was 
found to be 158.2°C - 160°C and the Rf value was 0.65. The compound has not been synthesized 
before and can be subjected for further biological evaluation or can be used as a precursor to 
make diesters. Triethyl amine (TEA) was used as a base that also acts as a nucelophile to attack 
the carbonyl carbon of benzoyl chloride. This resulted in the formation of a salt that acted as an 
electrophile to attack the hydroxyl group in RV. The hydroxyl group at para position (4’) got 
attacked because of acidity as shown in scheme 2. During the course of reaction, hydrogen 
chloride was produced that was removed by the reaction with TEA forming a salt, 
triethylammonium chloride. Removal of hydrogen chloride was essential for the reaction to 
proceed further. The integration of peaks in NMR spectrum was carried out on the basis of 
44 
 
aromatic hydrogen versus non- aromatic hydrogen. The ratio of aromatic to non-aromatic 
hydrogen was 22:2 that could be obtained by adding the integration values. The peaks on the 
higher field were due to solvents and moisture. Attempts to dry the sample were made, but the 
peaks were still present.  There were all together 19 different carbons were confirmed by the 19 
peaks at 
13
C spectrum. The IR spectrum was used to confirm the presence of carbonyl groups 
between 1735- 1750 cm
-1
as indicated on the spectrum. There was no stretch to indicate the 
presence of hydroxyl group around the region of 3200-3500 cm
-1
. All these results confirmed the 
formation of triester which is compound 1.  
Synthesis of 3, 4’, 5- tri (toluyloxy) stilbene 
 
Compound 2was obtained as a white solid after the purification using gradient column 
chromatography.  The compound had a melting point of 156.5-157.2°C   and Rfof 0.7. It is a 
novel triester derivative of RV which can be used either to form diester by hydrolyzing the para 
position substituent using a hydrolytic enzyme or it can be subjected for biological evaluation to 
test its bioavailability. The NMR spectrum was integrated separately for aromatic and non-
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aromatic hydrogen. The methyl H’s of toluyl group was made a reference by normalizing it and 
integrating other hydrogen present in the compound. NMR spectrum still indicates the presence 
of some impurities so 
13
C spectrum was not taken for this compound. The IR spectrum was used 
just to confirm the introduction of ester group. There was no indication for any peaks for 
hydroxyl group around 3200-3500 cm
-1
, which means the esterification reaction was carried out 
successfully. 
Synthesis of 3, 4’, 5- tri (2”-butenoyloxy) stilbene
 
Compound 3 was obtained as brown dense oil with a moderately high yield of around 
75%. Repeated attempts to purify the compound using column chromatography with various 
solvent systems were made but were not successful. The TLC indicated the presence of multiple 
products. It was a possibility for the double bond in ester chain to have different configuration 
(cis and trans) that led to multiple products with similar polarity causing difficulty in separation. 
The crotonyl chloride used was a mixture of both cis and trans isomer. It was a novel derivative 
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of resveratrol that could be subjected for biological evaluation after further purification. Even 
though the NMR spectrum showed some impurities, most of peaks for the hydrogen were 
accounted. There were three different kinds of hydrogen in the ester chain that is shown on the 
1
H NMR spectrum. The farthest peak at the high field represents the hydrogens at methyl group 
of the ester chain and then the alkene hydrogens. All the peaks are not accounted for, which 
means there were some impurities. Various attempts to purify the compound were not successful. 
As a result, the compound was not pure to the publishable standard.  IR spectrum was used to 
make sure the hydroxyl groups were converted to the ester group by the esterification reaction. 
The three carbonyl groups are represented by the peaks at 1734 cm
-1
and there are not any peaks 
corresponding to hydroxyl group. These entire spectrums confirmed the formation of compound 
3and indicated some impurities.  
Conclusions 
The objectives of the research were fulfilled with the synthesis of new RV triester (1, 2, 
& 3) derivatives. All of these compounds are the new derivatives of RV that has not been 
synthesized before. As per the standards of Journal of America Chemical Society, compound 1 is 
publishable while 2 and 3 are not pure enough. The initial goal was to synthesize diesters by 
hydrolyzing the ester chain at para position, but the objective was changed during the course of 
research. Chemical esterification of phenolic compound was the primary synthetic route that was 
used during the course of research.  With this route, there were formation of many side products 
that cost time, energy, and chemicals for purification. Also, it was not easy to separate the 
impurities, the case with compound 3. It is primarily because of unselective nature of reaction. 
Various attempts were made to make the reaction selective and to increase yield. The purity of 
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the product was confirmed using 
1
H and 
13
C NMR. The confirmation of introduction of carbonyl 
group and the disappearance of hydroxyl group in the novel derivatives were confirmed by IR.   
All the compounds are new so can be subjected to biological evaluation. A similar triester 
derivative of RV has been synthesized and reported to have much better bioavailability than RV.  
Various future works can be carried out on these new derivatives. As has been investigated 
before
49
, similar compounds like 1, 2, & 3 have biological potential as anti-cancer agents with 
increased solubility and bioavailability. Collaborations with Dr. Deling Yin have used RV 
derivatives in the past to pursue pharmaceutical applications. It is anticipated that compound 1-3 
will also be investigated along these lines
49
. The triester derivatives can be used as a precursor 
for synthesizing new derivatives (Scheme 13). 
 
Scheme 13. Future Reactions of the New Triester 
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The enzymatic hydrolysis can be carried out using an enzyme lipase like C. Antarctica 
that will selectively hydrolyze the ester group at 4’ position. This position is less sterically 
hindered than the 3’ and 5’ position. The next step after the enzymatic hydrolysis can be the 
conversion of alcohol group into a variety of functional groups through Mitsunobu reaction. Oye 
Mitsunobu discovered the reaction that uses triphenylphosphine and an azodicarboxylate like 
diethyl azodicarboxylate (DEAD). The reaction proceeds with inversion of configuration on the 
alcohol carbon. The order of addition of reagents is crucial, typically the alcohol, acidic 
nucleophile, triphenyl phosphine are dissolved in THF, then DEAD added slowly to the mixture 
and stirred for about 12 h. Various acid and ester derivatives have shown increased biological 
activities and better solubility so the prospects and potential of compounds 1, 2, &3 to make 
other derivatives are huge.    
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CHAPTER 3 
EXPERIMENTAL 
General Methods 
All the reagents used during the course of the experiment except resveratrol (RV) and 
crotonyl chloride were purchased from Sigma (St Louis, MO, USA) and used without further 
purification.  RV and crotonyl chloride were purchased from Tokyo Chemical Industry Co. Ltd 
(Tokyo, Japan) and used as supplied. Proton (
1
H) and Carbon-13 (
13
C) NMR spectra were taken 
from JOEL-NMR Eclipse spectrometer operating at 400 MHz and 100 MHz for proton and 
carbon nuclei respectively. Chemical shifts were recorded as delta values in parts per million 
(ppm) relative to TMS. The multiplicity of the signals was documented as: s, singlet; d, doublet; 
m, multiplet. CDCl3 and CD3COCD3 were used as solvents for NMR unless otherwise stated. 
The infrared spectrum was obtained using a Shimadzu FTIR Presctige-21. Silica gel for gravity 
column filtration was used as a stationary phase, while different mixtures of solvents were used 
as eluents to carry out the column chromatography. Thin Layer Chromatography (TLC) was 
conducted with UV active silica gel plates using suitable solvent mixtures that were then viewed 
under UV lamp using short wave. All mass measurements were taken using Ohaus Adventure 
Pro AV114 scale unless otherwise stated. Melting points of the compounds were recorded using 
Thermo Scientific 9100 instrument.  
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Experimental Procedures 
Synthesis of 3, 4’, 5-tri (benzoyloxy) stilbene, 1 
In a 50 mL round bottom flask, resveratrol (0.73 g, 3.18 mmol) was dissolved in 20 mL 
acetone. Benzoyl chloride (2.32 mL, 20 mmol), and triethyl amine (2.79 mL, 20 mmol) were 
added and the mixture was stirred for 48 hours under nitrogen. A TLC was done every 12 hours 
to observe the progress of the reaction and to confirm the formation of minimal side products. 
The mixture was acidified using 2N HCl (pH < 5). The resulting mixture was extracted by ethyl 
acetate (2×25 mL), washed with saturated sodium bicarbonate solution (2×10mL) to removes 
excess acid, and dried over anhydrous magnesium sulfate. The crude solution was concentrated 
and purified by column chromatography (30:70 v/v, acetone:hexane). Compound 1{C35H25O6} 
(1.55 g, 90%), M.P = 149.6 – 151°C, Rf value = 0.65 was obtained as white solid. 
1
H NMR (400 
MHz, CDCl3, δ, ppm), 7.3 (d, 2H), 7-8.2 (m, 22H, Ar-H), 
13
C NMR (100 MHz, CDCl3,δ, ppm), 
114.8, 117.2, 122.6, 127.9, 128.9, 129.3, 130, 130.2, 130.23, 130.5, 130.7, 134, 134.6, 135.5, 
139.9, 151, 153.3, 164.9, 165.2. IR (cm
-1
) 1732.08 (C=O stretch), 1701.22, 1593.2, 1585.49, 
1504.48, 1494.83. 
Synthesis of 3,4’,5-tri(toluyloxy) Stilbene, 2 
To a one-neck 50 mL round bottom flask were added resveratrol (0.7 g, 3.1 mmol), 
acetone (20 mL), toluoyl chloride (2.64 mL, 20 mmol), and triethyl amine (2.79 mL, 20 mmol). 
The mixture was stirred at room temperature under nitrogen for 48 hours.  A TLC was done 
every 12 hours to check the progression of the reaction and the formation of products. The 
mixture was acidified using 2N HCl (pH<5). A mixture was obtained that was extracted in the 
organic layer by means of ethyl acetate (2× 20 mL) and washed with saturated sodium 
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bicarbonate solution (2× 10mL) to remove excess acid. Anhydrous magnesium sulfate was used 
to absorb the moisture and dry the product. Gravity filtration was used to remove the magnesium 
salt from the solution. The reaction mixture was concentrated and purified using column 
chromatography (40:60 v/v, acetone: hexane) to give compound 2 {C35H30O6} (1.430g, 79%). 
M. P= 156.5-157.2°C. Rf value = 0.7 (Acetone/ Hexane, 30:70, V/V), 
1
H NMR (400 MHz, 
CDCl3, δ, ppm), 7-8.2 (m, 19H, Ar-H), 7.5(d, 2H), 2.5 (s, 9H) IR (cm
-1
) 2922.16, 2877.79, 
2852.72, 1735.93 (C=O stretch), 1714.72, 1693.5, 1683.86. 
 
Synthesis of 3, 4’, 5-tri (2”-butenoyloxy) Stilbene, 3 
To a one-neck 50 mL round bottom flask were added resveratrol (0.726 g, 3.18 mmol), 
acetone (20 mL), crotonyl chloride (1.92 mL, 20 mmol), and triethyl amine (2.79 mL, 20 mmol). 
The mixture was stirred under nitrogen atmosphere for 48 hours with TLC performed every 12 
hours. A TLC was done to check the progression of reaction and to check the number of products 
being formed during the course of the reaction. The mixture was acidified was using 2N HCl 
keeping pH less than 5. Ethyl acetate (2× 20 mL) was used to extract the crude product that was 
then washed with saturated sodium bicarbonate to remove any leftover acid. The organic layer 
was dried using anhydrous magnesium sulfate. The magnesium salt was filtered using gravity 
and purified with column chromatography (10-40% acetone to hexane in volume) to give 
compound 3{C26H24O6} (1.04 g, 75%).  Rf value = 0.60 (Acetone/ Hexane, 30:70, V/V), 
1
H 
NMR (400 MHz, CDCl3, δ, ppm), 6.8-7.5 (stilbene, 9H), 6-6.1 (d, 2H, vinylic), 1.9 (s, 9H, CH3). 
IR (cm
-1
) 2927.94, 2926.01, 1734.01 (C=O stretch), 1676.14, 1654.92, 1625.99, 1608.63, 
1602.85, 1598.99, 1591.27. 
52 
 
REFERENCES 
1. University of Oregon. Mapping History. http://mappinghistory.uoregon.edu/english/ 
index.html (accessed Nov 15, 2012) 
2. Rates, S. Plant as source of drugs. Elsevier Toxicon.2001, 39, 603-613.  
3. Fremon, L. Biological effects of resveratrol. Elseiver Life Sciences.2000, 66, 663-673. 
4. Jang, M.; Cai, L.; Udeani, G. O.; Slowing, K. V.; Thomas, C. F.; Beecher, C. W. W.; 
Fong, H. H. S.; Farnsworth, N. R.; Kinghorn, A. D.; Mehta, R. G.; Moon, R. C.; et al. 
Science 1997, 275, 218–220.  
5. Chen, L.; Zhang, Y.; Sun, X.; Li, H.; LeSage, G.; Javer, A.; Zhang, X.; Wei, X.; Jiang, Y.; 
Yin, D. Synthetic resveratrol aliphatic acid inhibits TLR2-mediated apoptosis and an 
involvement of Akt/GSK3β pathway. Bioorg. Med. Chem. 2009, 17, 4378-4382.  
6. Sinclair, D.; Baur, J. Therapeutic potential of resveratrol: the in vivo evidence. Nature Rev. 
Drug Discovery. 2006, 5, 493-506. 
7. Mayo Clinic. Health Information. http://www.mayoclinic.com/health/cancer-
prevention/CA00024/NSECTIONGROUP=2 (Accessed February 24, 2013) 
8. National Cancer Institute. Cancer Topics. http://www.cancer.gov/cancertopics (Accessed 
February 10, 2013) 
9. Medical News Today; what is Cancer? What Causes Cancer? 
http://www.medicalnewstoday.com/info/cancer-oncology (Accessed December 20, 2012)  
10. Gerber, D. Targeted Therapies: A New Generation of Cancer Treatments. Am Fam 
Physician. 2008, 77, 311-319.  
53 
 
11. Wust, P.; Hilderbrandt, B.; Sreenivasa, G.; Rau, B.; Gellermann, J.; Riess, H.; Felix, R.; 
Schlag, PM. Hyperthermia in combined treatment of cancer. Lancet Oncol. 2002, 8, 487-
97. 
12. Agostinis, P.; Berg, K.; Cengel, K.; Foster, T.;  Girotti,  A.; Gollnick,  S.; Hahn 
S.;  Hamblin,  M.;  Juzeniene, A.; Kessel, D.; Korbelik,  M.; Moan, J.; Mroz,  P.; Nowis,  
D.; Piette, J.; Wilson B.; Golab, J. Photodynamic therapy of cancer: an update. Pub Med. 
2011, 61, 250-81. 
13. Wagner-Dobler, I.; Beil, W.; Lang, S.; Meiners, M.; Laatsch, H. Integrated Approach to 
Explore the Potential of Marine Microorganisms for the Production of Bioactive 
Metabolites. Advances in Biochemical Engineering/Biotechnology. 2002, 74, 208-238. 
14. Sakarkar,D.; Seshmukh,V. Ethnopharmacological review of traditional medicinal plants 
for anticancer activity. International Journal of Pharma Tech Research. 2011,3,298-308.  
15. Duflos,A.; Kruczynski, A.; Barret, J. Novel Aspects of natural and modified vinks 
alkaloids. Current Medicinal Chemistry. 2002, 2, 55-70. 
16. Yun-San Yip, A.; Yuen-Yuen Ong, E.; Chow, C. Vinflunine: clinical perspectives of an 
emerging anticancer agent. Expert Opinion on Investigational Drugs. 2008, 17, 583-591.  
17. Walle, T.;  Otake, Y.; Brubaker, J.; Walle,  U.; Halushka, P. Disposition and metabolism 
of the flavonoid chrysin in normal volunteers. Br J ClinPharmacol. 2001, 51, 143–146. 
18. Mukhtar, H.; Das, M.; Khan, W.; Bik, D.; Exceptional activity of tannic acid among 
naturally occurring plant phenols in protecting against 7,12-dimethybenz(a)anthraxcene-, 
benzo(a)pyrene-, 3-methylcholanthrene-, and N-methyl-Nnitrosourea- induced skin 
tumorigenesis in mice. Cancer Res. 1988, 48, 2361–2365. 
54 
 
19. Acevedo-Duncan, M.; Russell, C.; Patel, S.; Patel, R. Aloe-emodin modulates PKC 
isozymes, inhibits proliferation, and induces apoptosis in U-373MG glioma cells. 
IntImmunopharmacol. 2004, 4, 1775–1784. 
20. Block, J. Wilson &Gisvold’s Textbook of Organic Medicinal and Pharmaceutical 
Chemistry.; Lippincott Williams&Wilkins: Hagerstown, 2004. 
21. Yamada, T.; Ito, S. Chemical Defense Responses of Wilt-Resistant Pine Species against 
Bursaphelencusxylophilus, Ann Phytopathol. Soc. Jpn. 1993, 59, 666 – 672.  
22. Pons, L. Pterostilbene’s healthy potential. Agricultural Research Magazine, Nov/Dec 
2006, pp 6-7.  
23. Johnson, T. The “Other” Resveratrol: A Novel Method to Stimulate the Genetic Effects 
of Caloric Restriction. Life Extension,Winter 2009, pp 9-12.  
24. Piotrowska, H.; Kucinska, M.; Murias, M. Biological Activity of Piceatannol: leaving the 
shadow of resveratrol. Pub Med. 2012, 750, 60-82. 
25. Kwon, J.Y.; Seo, S. G.; Heo, Y.S.; Yue, S.; Cheng, J.X.; Lee, K.W.; Kim, K.H.         
Piceatannol, A Natural PolyphenolicStilbene, inhibits adipogenesisvia modulation of 
mitotic clonal expansion and insulin receptor dependent insulin signaling in the early 
phase of differentiation.J. Biol. Chem. 2012, 287, 44498-44507. 
26. Lai, T.N.H.; Herent, J.Q.; Nguygen, T.B.T.; Rogez, H.; Larondelle, Y.; Andre, C.M. 
Piceatannol, a potent bioactive stilbene, as major phenolic component in 
Rhodomyrtustomentosa.Elseiver Food Chemistry.2013, 138, 1421-1430.  
27. Jeong, E.; Lee, H.-R.; Pyee, J.; Park, H. Pinosylvin Induces Cell Survival, Migration and 
Anti-Adhesiveness of Endothelial Cells via Nitric Oxide Production. 
PhytotherapyReseach.2012, 10, 4770. 
55 
 
28. Burns, J.; Yokota, T.; Ashihara, H.; Lean, ME.; Crozier, A. Plant foods and herbal 
sources of resveratrol. J Agric Food Chem. 2002, 50, 3337-3340.  
29. Rimando, AM.; Kalt, W.; Magee, JB.; Dewey, J.; Ballington, JR. Resveratrol, 
pterostilbene, and piceatannol in vaccinium berries. J Agric Food Chem. 2004, 52, 4713-
4719.   
30. Sanders, TH.; McMichael,RW.;Hendrix, KW. Occurrence of resveratrol in edible 
peanuts. J Agric Food Chem. 2000, 48, 1243-1246. 
31. Petyaev, I.M.; Bashmakov, Y.K. Could cheese be the missing piece in the French 
paradox puzzle? Elsevier Med. Hypotheses. 2012, 79, 746-9. 
32. Kopp, P. Resveratrol, a phytoestrogen found in red wine. A possible explanation for the 
conundrum of the ‘French paradox’?European Journal of Endocrinology. 1998, 138, 
619–620. 
33. Fulda, S. Resveratrol and derivatives for the prevention and treatment of cancer. Drug 
Discovery Today. 2010, 15, 757-65.  
34. Wolter, F.; Stein, J. Biological activities of resveratrol and its analogs. Drugs Fut. 2002, 
27, 949. 
35. Gehm, B.D.; McAndrews, J.M.; Chien, P.Y.; Jameson, L. Resveratrol, a polyphenolic 
compound found in grapes and wine, is an agonist for the estrogen receptor. PNAS. 1997, 
94, 14138-14143.  
36. Jiang, Y.L. Design, synthesis and spectroscopic studies of resveratrol aliphatic acid 
ligands of human serum albumin. Bioorg. Med. Chem. 2008, 16, 6406-6414.       
37. Jang, M.; et al. Cancer Chemopreventive Activity of Resveratrol, a Natural product 
Derived from Grapes. Science. 1997, 275, 218-20. 
56 
 
38. Bhat, K.P.; Pezzuto, J.M. Cancer Chemopreventive activity of resveratrol. Ann N Y Acad 
Sci. 2002, 957, 210-29. 
39.   Pallas, M.; Casadesus, G.; Smith, M.A.; Coto-Montes, A.; Pepegri, C.; Vilaplana, J.; 
Camins, A. Resveratrol and Neurodegenerative Diseases: Activation of SIRT1 as the 
Potential Pathway towards Neuroprotection. Curr. Neurovasc. Res. 2009, 6, 70-81.  
40. Kapetanovic, I.M.; et al. Pharmacokinetics, oral bioavailability, and metabolic profile of 
resveratrol and its dimethylether analog, pterostilbene in rats. Cancer Chemotherapy and 
Pharmacology. 2011, 68, 593-601.  
41. Chen, X.; et al. Stereospecific determination of cis- and trans-resveratrol in 
rat plasma by HPLC: application to pharmacokinetic studies. Biomed.Chromatogr.2007, 
21, 257-265. 
42. Walle, T.; Hsieh, F.; DeLegge M.; Oatis, J. E.; Walle, U.K. High absorption but very low 
bioavailability of oral resveratrol in humans. Drug Metabolism and Disposition. 2004, 
32, 1377-1382. 
43. Frojdo, S.; Durand, C.; Pirola, L. Metabolic effects of resveratrol in mammals – a link 
between improved insulin action and aging. Curr. Aging Sci. 2008, 1, 145-51. 
44. Amri, A.; Chaumeil, J.C.; Sfar, S.; Charrueau, C. Adminstration of resveratrol: What 
formulation solutions to bioavailability limitations? J. Control Release. 2012, 158, 182-
93. 
45. Rivera, L.; Mor´on, R.; Zarzuelo, A.; Galisteo, M. Long-term resveratrol administration 
reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. 
Biochemical Pharmacology. 2009, 77, 1053-63. 
 
57 
 
46. Wang, M.; et al. J. Agric. Food Chem. 1999, 47, 3975.  
 
47. Horvath, Z.; et al. Novelresveratrolderivativesinduceapoptosisandcause cell cycle 
arrestinprostatecancercelllines. Anticancer Res. 2007, 27, 3459–3464. 
48. Horvath,Z.;et al.Cytotoxicandbiochemicaleffectsof3,3’,4,4’,5,5’- 
hexahydroxystilbene,anovelresveratrolanaloginHL-60humanpromyelocytic leukemia 
cells. Exp. Hematol. 2006, 34, 1377–1384 
49. Yin, Deling.;et al. Synthetic resveratrol aliphatic acid inhibits TLR2-mediated apoptosis 
and an involvement of Akt/GSK3 βpathway. Bioorganic and Medicinal Chemistry. 2009, 
17, 4378-4382.  
50. Queiroz, A. N.; Gomes, B. A.Q.; Moraes, W. M.; Borges, R. S. A theoretical antioxidant 
pharmacophore for resveratrol. Eur. J. Med. Chem. 2009, 44, 1644-1649.  
 
 
 
 
 
 
 
 
 
 
 
58 
 
APPENDICES 
Appendix A: 
1
H NMR spectrum of compound 1 in CCl3D 
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Appendix B: 
13
C NMR spectrum of compound 1 in CCl3D 
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Appendix C: IR spectrum of compound 1 
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Appendix D: 
1
HNMR Spectrum of Compound 2 in CDCl3 
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Appendix E. IR Spectrum of Compound 2 
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Appendix F: 
1
HNMR Spectrum of Compound 3 in CDCl3 
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Appendix G: IR Spectrum of Compound 3
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1
H NMR Spectrum of RV in DMSO 
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